U.S. Oncology Based Molecular Diagnostics Market: Growth, Trends, and Opportunities
The U.S. Oncology Based Molecular Diagnostics Market is witnessing significant growth driven by the increasing prevalence of cancer, rising demand for early diagnosis, and advancements in precision medicine. Valued at USD 1.34 billion in 2024, the market is projected to expand at a CAGR of 5.5% from 2025 to 2034, reaching USD 2.29 billion. Oncology molecular...
0 Σχόλια 0 Μοιράστηκε 84 Views 0 Προεπισκόπηση